See today's BioWorld MedTech
To read the full story, subscribe or sign in.

Mix of opinion on Vertex deal; Sigilon coming on strong

Sep. 6, 2019
By Randy Osborne
BioWorld MedTech Deals and M&A Stem cells Acquisition Diabetes